Please login to the form below

Not currently logged in
Email:
Password:

Life restructure sees management reshuffle

Reg Manser leaves creative director post to take up chief creative officer role

Life Steve Martin Elinor Washbrook Ben Dragon 
Pictured (left to right): Steve Martin, Elinor Washbrook and Ben Dragon  

Windsor, UK-based healthcare advertising agency Life has restructured its operations in a move that sees several senior changes.  

Heading these up is Reg Manser, who steps down as the agency's creative director in order to assume the role of chief creative officer.  

As CCO he will work alongside Life CEO Juliet La Marque on the company's creative strategy and business development.  

In this position Manser will be supported by Matt Leeming, who assumes the newly-created position of strategy director, advising clients on marketing strategy and brand development.  

Taking over as creative director is Steve Martin, who brings to the role big-brand experience gained in major consumer agencies as well as nearly a decade in pharmaceutical advertising.  

Martin will be supported by Elinor Washbrook, who is promoted to head of copy and will manage Life's team of medical copywriters.  

Life, which said the changes reflect its role as an integrated creative communications agency, rounds out its changes by appointing Ben Dragon as head of art to oversee the agency's design output.

9th October 2013

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics